Fang, Fang
Hazegh, Kelsey
Mast, Alan E.
Triulzi, Darrell J.
Spencer, Bryan R.
Gladwin, Mark T.
Busch, Michael P.
Kanias, Tamir
Page, Grier P.
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (R01 HL134653, R01 HL134653, HHSN2682011-00001I, 00002I, 00003I, 00004I, 00005I, 00006I, 00007I, 00008I, and 00009I, HHSN2682011-00001I, 00002I, 00003I, 00004I, 00005I, 00006I, 00007I, 00008I, and 00009I, HHSN2682011-00001I, 00002I, 00003I, 00004I, 00005I, 00006I, 00007I, 00008I, and 00009I, HHSN2682011-00001I, 00002I, 00003I, 00004I, 00005I, 00006I, 00007I, 00008I, and 00009I, HHSN2682011-00001I, 00002I, 00003I, 00004I, 00005I, 00006I, 00007I, 00008I, and 00009I, R01 HL134653, R01 HL134653)
RTI International (0291014.202.603, 0291014.202.603)
Article History
Received: 9 December 2021
Accepted: 4 March 2022
First Online: 23 March 2022
Declarations
:
: The REDS-III study was conducted under regulations applicable to human subject research. Written informed consent was obtained from all human subjects in accordance with the Declaration of Helsinki, under research protocols approved by institutional review boards from each participating blood center, form the REDS-III Central Lab at the Data Coordinating Center (RTI International).
: Not applicable.
: MPB declares NHLBI REDS salary support. MTG declares industry consulting relationships with Pfizer, Bayer, Fulcrum, and Novartis. All other authors declare no competing interests.